logo

SNTI

Senti Biosciences·NASDAQ
--
--(--)
--
--(--)
3.73 / 10
Netural

Analyst sentiment is mixed: 50% Strong Buy, 50% Buy, yet historical win rates are zero and market expectation is pessimistic with a 19% price decline. Fund‑flow metrics are good (7.45/10) showing inflows across small to large investors, but overall trend remains negative.

FundamentalSentiment(3.73)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

50%

Buy

50%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-12-09
InstitutionChardan Capital
Times predicted4
Historical Win Rate0.0%
Is money flowing into or out of SNTI?
  • SNTI holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.73/10 (Netural).